Macromoltek Overview
- Founded
- 2010

- Status
- Private
- Employees
- 13

- Latest Deal Type
- Later Stage VC
- Investors
- 8
Macromoltek General Information
Description
Developer of molecular modeling software designed to analyze potential antibody drug candidates. The company's platform uses its data algorithms to optimize the selection process, solves antibody structures computationally, and offers an online workspace, enabling researchers to make new discoveries by keeping the focus on their science.
Contact Information
Website
www.macromoltek.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 2500 West William Cannon Drive
- Suite 204
- Austin, TX 78745
- United States
+1 (512) 000-0000
Macromoltek Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC | 01-Jan-2020 | 00000 | Completed | Generating Revenue | ||
7. Later Stage VC | 00000 | 00000 | Completed | Generating Revenue | ||
6. Accelerator/Incubator | 19-Mar-2018 | 00000 | 00000 | 00.000 | Completed | Generating Revenue |
5. Seed Round | 01-Jan-2018 | Completed | Generating Revenue | |||
4. Grant | 20-Aug-2016 | 00000 | Completed | Startup | ||
3. Accelerator/Incubator | 01-Mar-2015 | Completed | Startup | |||
2. Grant | 01-Jan-2015 | $150K | Completed | Startup | ||
1. Accelerator/Incubator | 10-Dec-2014 | Completed | Startup |
Macromoltek Patents
Macromoltek Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210246203-A1 | Compositions and methods for treating progressive neurodegenerative diseases | Pending | 21-Aug-2018 | 000000000 | |
US-20140100834-A1 | Computational methods for analysis and molecular design of antibodies, antibody humanization, and epitope mapping coupled to a user-interactive web browser with embedded three- dimensional rendering | Abandoned | 04-Oct-2012 | 000000000 |
Macromoltek Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Monica Berrondo Ph.D | Co-Founder & Chief Executive Officer | ||
Susana Kaufmann | Co-Founder & Chief Technology Officer |
Macromoltek Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMacromoltek Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
DCVC | Venture Capital | Minority | 000 0000 | 000000 0 | |
Y Combinator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
Ataria Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
DCVC Bio | Venture Capital | Minority | 000 0000 | 000000 0 | |
Neotribe Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |